Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTXR
DateTimeSourceHeadlineSymbolCompany
27/12/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
27/12/202422:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CTXRCitius Pharmaceuticals Inc
27/12/202422:00PR Newswire (US)Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:CTXRCitius Pharmaceuticals Inc
20/12/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
26/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
25/11/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
25/11/202413:03PR Newswire (US)Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to ApprovalNASDAQ:CTXRCitius Pharmaceuticals Inc
22/11/202414:00PR Newswire (US)Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock SplitNASDAQ:CTXRCitius Pharmaceuticals Inc
18/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
18/11/202421:05PR Newswire (US)Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct OfferingNASDAQ:CTXRCitius Pharmaceuticals Inc
18/11/202413:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CTXRCitius Pharmaceuticals Inc
15/11/202418:30PR Newswire (US)Citius Pharmaceuticals Announces $3 Million Registered Direct OfferingNASDAQ:CTXRCitius Pharmaceuticals Inc
13/11/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
11/11/202413:45PR Newswire (US)Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid TumorsNASDAQ:CTXRCitius Pharmaceuticals Inc
27/09/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
13/09/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
11/09/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
05/09/202420:30PR Newswire (US)Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CTXRCitius Pharmaceuticals Inc
05/09/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
05/09/202412:30PR Newswire (US)Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in OncologyNASDAQ:CTXRCitius Pharmaceuticals Inc
30/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
30/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTXRCitius Pharmaceuticals Inc
16/08/202420:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTXRCitius Pharmaceuticals Inc
16/08/202420:34Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:CTXRCitius Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CTXR